WHO: COVID-19 Global Health Emergency Continuing; Monkeypox Cases Increase by 50% 12/07/2022 Elaine Ruth Fletcher With a surge in cases and the rapid rise of new subvariants, the COVID-19 pandemic continues to be a global health emergency posing significant risks to public health, a WHO committee of public health experts has concluded. The statement by the COVID-19 Emergency Committee, was published Tuesday, four days after experts gathered for their 12th […] Continue reading -> Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> Posts navigation Older postsNewer posts
Some 1.1 Billion COVID-19 Vaccine Doses Likely Wasted Since Rollout Began 11/07/2022 Editorial team Some 1.1 billion COVID-19 vaccines are likely to have been wasted since the global rollout began, according to new findings by Airfinity, a global health surveillance firm. Airfinity’s analysis, released Monday, assumed a 10% wastage rate from June 2021 when global dose sharing began. This rate is taken from confirmed wastage in the United States […] Continue reading -> European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> Posts navigation Older postsNewer posts
European Medicines Agency Recommends Second COVID Booster for People Over 60 – as WHO Ponders Status of COVID Emergency 08/07/2022 Elaine Ruth Fletcher With cases of Omicron BA.4 and BA.5 soaring in Europe and around the world, the European Medicines Agency (EMA) recommends everyone 60 and older get a second COVID-19 booster shot. EMA’s recommendation came shortly before WHO reconvened its COVID Emergency Committee on Friday to reconsider its global recommendations for the pandemic – and if the […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> Posts navigation Older postsNewer posts
Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> Posts navigation Older postsNewer posts
Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> Posts navigation Older postsNewer posts
WTO Agrees on Limited IP Waiver for COVID-19 Vaccines and Package to Reduce Harmful Fishing Subsidies 17/06/2022 John Heilprin & Elaine Ruth Fletcher Limited IP waiver text says WTO members “will decide” on inclusion of COVID-19 tests and treatments within six months. The World Trade Organization’s first ministerial conference in four and a half years reached agreement early Friday morning on what officials described as “an unprecedented outcome” of six agreements, including a deal to curb some fishing […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> Posts navigation Older postsNewer posts
Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> Posts navigation Older postsNewer posts
Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> Posts navigation Older postsNewer posts